Mepolizumab Reduced Asthma Attacks in Urban Youth
A monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma.
Tag: antibodies
All
Latest
All
Latest
AstraZeneca Long-Acting Monoclonal Antibodies Authorized
The FDA has issued an emergency use authorization for AstraZeneca’s Evusheld (tixagevimab and cilgavimab) to prevent COVID-19 in certain adults and children.
All
Latest
Cytokine Levels Could Predict Asthma Patients’ Response to Benralizumab
Levels of inflammatory cytokines in patients with severe asthma may predict responses to the monoclonal antibody benralizumab, a study in the Journal of Asthma suggests.
FDA Authorizes Symbiotica COVID-19 Self-Collected Antibody Test
The US FDA has issued an EUA for the Symbiotica COVID-19 Self-Collected Antibody Test System, the first antibody test authorized for use with home collected dried blood spot samples.
Read More
FDA to Review Expanded Application of Dupixent for Childhood Asthma
The FDA will review an sBLA for Dupixent (dupilumab) as an add-on treatment for children aged 6 to 11 years with uncontrolled moderate-to-severe asthma.
Read More
Monoclonal Antibodies Effective against MERS Coronavirus in First Human Trial
The first Phase 1 clinical trial of two monoclonal antibodies to treat Middle East respiratory syndrome coronavirus (MERS-CoV) found that they were well tolerated and generally safe when administered simultaneously to healthy adults.
Read More
Low Reinfection Risk for People with SARS-CoV-2 Antibodies
People who have had evidence of a prior infection with SARS-CoV-2 appear to be well protected against being reinfected with the virus, at least for a few months.
Read More
FDA Authorizes Monoclonal Antibodies for COVID-19
The FDA authorized Eli Lilly and Co’s bamlanivimab and etesevimab, monoclonal antibodies for the treatment of mild to moderate COVID-19.
Read More
Mothers Pass SARS-CoV-2 Antibodies to Newborns
Pregnant women infected with COVID-19 who were either asymptomatic or symptomatic passed SARS-CoV-2 antibodies to their newborns during pregnancy via the placenta.
Read More
COVID-19 Antibodies Protect for at least Six Months
Patients who recover from COVID-19 are protected against the virus for at least six months, and likely much longer, according to a study published in Nature by researchers at Rockefeller University.
Read More
SARS-CoV-2 Antibody Test Helps Select Donor Blood Samples for Therapeutic Use
A new COVID-19 antibody assay was able to detect IgG and IgM antibodies to determine viable donor samples for therapeutic use and clinical trials.
Read More
Clinical Trials Testing Two Monoclonal Antibodies for COVID-19
A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy used for COVID-19.
Read More
FDA Authorizes Regeneron’s Monoclonal Antibody Treatment for COVID-19
The FDA issued an emergency use authorization for Regeneron’s casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in patients 12 and older.
Read More
‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die
Scientists have found that some people have antibodies against parts of their own immune system, allowing viruses to multiply rapidly.
Read More
FDA Authorizes Bamlanivimab for Treatment of COVID-19
The monoclonal antibody bamlanivimab reduced COVID-19-related hospitalization or ER visits in patients at high risk for disease progression within 28 days after treatment.
Read More